日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Structural and biochemical differences between non-catalytic and catalytic antibodies

非催化抗体和催化抗体在结构和生化方面的差异

期刊:MAbs
影响因子:7.3
doi:10.1080/19420862.2025.2503978
Uda, Taizo; Kato, Ryuichi; Shigeta, Yasuteru; Hirota, Shun; Kobayashi, Jun; Yoshida, Hisashi; Tsuyuguchi, Masato; Hengphasatporn, Kowit; Tsujita, Moe; Taguchi, Hiroaki; Hifumi, Emi
发表日期：2025
文献求助 收藏

Experimental and Computational Studies on Domain-Swapped Structure Stabilization of an Antibody Light Chain by Disulfide Bond Introduction

二硫键介导的抗体轻链结构域交换稳定作用的实验和计算研究 引言

期刊:Journal of Medicinal Chemistry
影响因子:6.8
doi:10.1021/acs.jmedchem.4c02570
Fitriana, Wahyu; Sakai, Takahiro; Duan, Lian; Hengphasatporn, Kowit; Shigeta, Yasuteru; Mashima, Tsuyoshi; Uda, Taizo; Hifumi, Emi; Hirota, Shun
发表日期：2024
文献求助 收藏

Structural and thermodynamic insights into antibody light chain tetramer formation through 3D domain swapping

通过三维结构域交换对抗体轻链四聚体形成进行结构和热力学分析

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-023-43443-4
Sakai, Takahiro; Mashima, Tsuyoshi; Kobayashi, Naoya; Ogata, Hideaki; Duan, Lian; Fujiki, Ryo; Hengphasatporn, Kowit; Uda, Taizo; Shigeta, Yasuteru; Hifumi, Emi; Hirota, Shun
发表日期：2023
文献求助 收藏

Direct conversion of a general antibody to its catalytic antibody and corresponding applications -Importance and role of Pro95 in CDR-3

通用抗体直接转化为催化抗体及其相应应用——Pro95在CDR-3中的重要性和作用

期刊:Proceedings of the Japan Academy Series B-Physical and Biological Sciences
影响因子:4.6
doi:10.2183/pjab.99.010
Hifumi, Emi; Taguchi, Hiroaki; Nonaka, Tamami; Uda, Taizo
发表日期：2023
文献求助 收藏

Obtaining Highly Active Catalytic Antibodies Capable of Enzymatically Cleaving Antigens.

获得能够酶促裂解抗原的高活性催化抗体

期刊:International Journal of Molecular Sciences
影响因子:4.9
doi:10.3390/ijms232214351
Nonaka Tamami, Taguchi Hiroaki, Uda Taizo, Hifumi Emi
其它
发表日期：2022
文献求助 收藏

A new algorithm to convert a normal antibody into the corresponding catalytic antibody.

一种将普通抗体转化为相应催化抗体的新算法

期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.aay6441
Hifumi Emi, Taguchi Hiroaki, Tsuda Haruna, Minagawa Tetsuro, Nonaka Tamami, Uda Taizo
其它
发表日期：2020
文献求助 收藏

New technologies to introduce a catalytic function into antibodies: A unique human catalytic antibody light chain showing degradation of β-amyloid molecule along with the peptidase activity

将催化功能引入抗体的新技术：一种独特的人类催化抗体轻链，可降解β-淀粉样蛋白分子并具有肽酶活性。

期刊:FASEB BioAdvances
影响因子:2
doi:10.1096/fba.1025
Hifumi, Emi; Taguchi, Hiroaki; Toorisaka, Eiichi; Uda, Taizo
发表日期：2019
文献求助 收藏